eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | myeloid leukemia |
| Comorbidity | C0011860|type 2 diabetes |
| Sentences | 2 |
| PubMedID- 20466781 | Context: the mechanism(s) by which imatinib improves glycemic control in chronic myeloid leukemia (cml) patients with type 2 diabetes remains unclear. |
| PubMedID- 23037470 | Rapid amelioration of hyperglycemia facilitated by dasatinib in a chronic myeloid leukemia patient with type 2 diabetes mellitus. |
Page: 1